about
Primary cardiac lymphoma (PCL) - diagnostic difficultiesA randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations.Elevated troponin I level assessed by a new high-sensitive assay and the risk of poor outcomes in patients with acute heart failure.Impaired hepato-renal function defined by the MELD XI score as prognosticator in acute heart failure.Clinical characteristics and predictors of in-hospital mortality in 270 consecutive patients hospitalised due to acute heart failure in a single cardiology centre during one year.Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.Hyperhomocysteinemia in patients with symptomatic chronic heart failure: prevalence and prognostic importance--pilot study.Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion.InterAtrial Shunt Device (IASD®) implantation - a novel treatment method for heart failure with preserved ejection fraction.Urinary levels of novel kidney biomarkers and risk of true worsening renal function and mortality in patients with acute heart failure.The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.Evaluation of Skeletal Muscle Function and Effects of Early Rehabilitation during Acute Heart Failure: Rationale and Study Design.Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failureValidation of transurethral intra‑abdominal pressure measurement in acute heart failureLiver function tests in patients with acute heart failureComparison of invasive and non-invasive measurements of haemodynamic parameters in patients with advanced heart failure[Clinical use of ventilation measurement during early phase of exercise in patients with chronic heart failure][Effect of sildenafil on haemodynamic parameters of pulmonary circulation and physical capacity in patients with systolic chronic heart failure with secondary severe pulmonary hypertension]Optimal management of cancer patients with acute coronary syndromeQ95396494
P50
Q36245501-92A6D49F-4051-47A9-8F89-AC00FB9F238DQ37583316-46935501-EEEC-4ED1-A515-6D14DD76A927Q38485131-21F35F3E-A2F5-40EE-B961-93E42E855ACDQ39161462-6F27DB99-F920-49FD-A24C-ED17227ABA84Q39317336-2C454680-9DB6-4AFA-8108-C05FC36FFBFFQ43418400-848809B6-2997-476F-A675-B50310B31A57Q48270321-5C46F7DA-48BD-4EBD-BC77-3D8821ACD5B5Q48422103-A050190B-0E85-461B-A977-DC03F9A586B9Q50068538-F9BF998B-E360-4D60-8190-A3D1EB28B530Q50863868-E8B05032-A857-40D3-854F-E545C72D44C1Q50925604-22C11B4E-3059-4417-A429-549460675ECFQ51648755-60D8107D-DC1E-4229-9D83-AA31DAF9207CQ55001900-81A887A0-B207-4CE5-A026-4BFB16782F97Q57422709-32C3B671-8663-4297-93AF-7DB32E8F63A8Q57911326-1D9031E7-783C-4B0A-A7BE-0E250E97E60DQ57911452-F5378D7A-32F8-463D-A51D-E4CD3D58F23DQ57911469-56B2C261-FDE3-4035-95EB-82BF1AA70008Q80272723-1A50AEE9-0D5B-4C69-9283-99D537CE2835Q84146157-73B711A0-0BC6-4CCB-AE6F-D98985548510Q88512941-019E8F6F-81A8-4487-A579-0F9EEA2C8ADDQ95396494-175D3D30-5127-4968-96B7-9B1F4CEEC336
P50
description
researcher ORCID ID = 0000-0003-1483-7381
@en
name
Robert Zymlinski
@ast
Robert Zymlinski
@en
Robert Zymlinski
@es
Robert Zymlinski
@nl
type
label
Robert Zymlinski
@ast
Robert Zymlinski
@en
Robert Zymlinski
@es
Robert Zymlinski
@nl
prefLabel
Robert Zymlinski
@ast
Robert Zymlinski
@en
Robert Zymlinski
@es
Robert Zymlinski
@nl
P31
P496
0000-0003-1483-7381